2 top ASX healthcare shares that could be market beaters

Nanosonics Ltd (ASX:NAN) and this ASX healthcare share have been tipped as market beaters. Here’s what you need to know…

| More on:
ASX share price movement represented by doctor pressing digitised screen with array of icons including one entitled health insurance

Image source: Getty Images

One area of the market which has performed exceptionally well over the last decade has been the healthcare sector.

Since this time in 2010, the S&P/ASX 200 Health Care index has risen a remarkable 450%. This compares to a more modest ~39% gain by the S&P/ASX 200 Index (ASX: XJO) over the same period, excluding dividends.

The good news for investors is that there are a number of healthcare shares that have been tipped to continue to outperform the market. Here are two:

Nanosonics Ltd (ASX: NAN)

One thing the pandemic has taught us, is that infection control is very important. This bodes well for infection prevention company Nanosonics. It is the name behind the industry-leading trophon EPR disinfection system for ultrasound probes. It is also aiming to launch several new products in the near future which have similar addressable markets. Though, it is worth noting that these launches continue to be delayed.

Nevertheless, one broker that thinks investors should be patient is UBS. The broker believes Nanosonics is a high-quality and structural growth story and expects the company to benefit from post-COVID infection prevention tailwinds. Its analysts have put a buy rating and $7.20 price target on the company’s shares.

ResMed Inc. (ASX: RMD)

ResMed is a sleep treatment-focused medical device company that has been growing at a very strong rate over the last few years. This has been driven by its industry-leading products in a sleep treatment market that is growing fast. Pleasingly, management remains confident on its outlook and notes that there are an estimated ~1 billion people impacted by sleep apnoea worldwide. From these, it believes just ~20% have been diagnosed.

Analysts at Credit Suisse believe the company is well-placed for growth and have recently upgraded ResMed’s shares to an outperform rating with a $31.00 price target. It believes ResMed is well-placed to benefit from a shift to home healthcare following the pandemic.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Nanosonics Limited. The Motley Fool Australia has recommended Nanosonics Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A young woman lifts her glasses with one hand as if to take a closer look at something as she has a look of surprised interest on her face with her mouth in an O shape.
Dividend Investing

2 ASX shares that could be buys for both growth and dividends

There are a select group of ASX shares that could deliver growth and income.

Read more »

A business man in soft-focus holds two fingers in the air in the foreground of the shot as he stands smiling in the background against a clear sky.
Broker Notes

Buy these 2 ASX shares on sale right now: top broker

A top broker has revealed two ASX shares which have fallen heavily but look like good buys.

Read more »

Growth Shares

Experts name 2 beaten down ASX growth shares to buy after the market meltdown

These beaten down growth shares could be in the buy zone...

Read more »

Three different hands against a blue backdrop signal thumbs up, indicating share price rise on the ASX market
Growth Shares

Analysts name 2 ASX shares to buy with ~50% upside potential

These ASX shares could have major upside potential according to analysts...

Read more »

A woman holds a lightbulb in one hand and a wad of cash in the other
Growth Shares

Why I would invest $10,000 into these ASX 200 shares right now

Here are a couple of ASX shares I would buy following recent market weakness.

Read more »

Concept images of four piles of coins, each getting higher, with trees on them.
Growth Shares

3 top ASX growth shares I’d buy next week

Xero is one of the ASX growth shares that I think looks good value today.

Read more »

A white and black clock face is shown with three hands saying Time to Buy reflecting Wilson Asset Management's two ASX share picks in its WAM Research portfolio
Growth Shares

Buy these great value 2 ASX growth shares: experts

Airtasker is one of the ASX shares that offers plenty of upside, a broker says.

Read more »

Person pointing finger on on an increasing graph which represents a rising share price.
Growth Shares

Here are 2 ASX growth shares experts have named as buys

Here are a couple of growth shares analysts are tipping as buys...

Read more »